×
Login
Username:
Password:
Register
Forget your password?
Click Here
Follow @SciVee
login
upload
Home
Journals
Conferences
Education
Search
All Content
All Content
Journals
Conferences
Education
Communities
SciveeCasts
Videos
All Content
Journals
Conferences
Education
Communities
SciveeCasts
Videos
Please enter at least 3 characters.
Module II - Section 3
by:
KuoOffice
May 26, 2010
DOI: 10.4016/18144.01
Share
Favorite
977
views
x
URL
Embed
Share
Please describe the reason for abuse:
Description:
Key Therapeutic Area: Anticoaugulation http://pharmacogenomics.ucsd.edu/
» More
Key Therapeutic Area: Anticoaugulation
http://pharmacogenomics.ucsd.edu/
« Hide
Authors:
Grace m. Kuo, Kelly c. Lee, Joseph d. Ma
Belongs to:
Pharmacogenomics Education Program
Safe and Effective Medication Therapy Management
Comments
Supplementary Materials
Figures
Loading comments
Related
More from this user
862
KuoOffice
Module II - Section 1
808
KuoOffice
Module II - Section 2
792
KuoOffice
Module II - Section 4
843
KuoOffice
Module II - Section 5
3612
KuoOffice
Pharmacogenomic Biomarkers for Prediction of...
1592
KuoOffice
Dr. Suzanne Bradbury's Pharmacy Practice at Vons
2944
KuoOffice
Dr. Binh Tran's Pharmacy Practice at Asian...
1322
KuoOffice
Understanding Functional Health Literacy and...
1446
KuoOffice
Pharmacist Interventions in the Medication...
2211
KuoOffice
Dr. Therese Clark’s Pharmacy Practice at...
Tags
Pharmacogenomics
Subject areas
genetics
pharmacy